Plunkett Research Online: UCB SA

UCB SA (UCBJF:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

UCB SA is a Belgian biopharmaceutical firm with operations in more than 40 countries. The firm’s main products are focused within the fields of immunology and neurology. UCB’s immunology product is used to treat rheumatoid arthritis, osteoporosis, axial spondyloarthritis, psoriatic arthritis, Chro.....



UCB SA
Ticker: UCBJF
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 32-2-559-99-99
Fax: 32-2-559-99-00
Address: 60, Allee de la Recherche
Brussels, 1070 Belgium

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals Development
Industrial Chemical Products
Allergy & Respiratory Treatments
Central Nervous System Disorder Treatments
ContactsDescription

Jean-Christophe TellierCEO
Detlef ThielgenCFO/Exec. VP
See More
UCB SA is a Belgian biopharmaceutical firm with operations in more than 40 countries. The firm’s main products are focused within the fields of immunology and neurology. UCB’s immunology product is used to treat rheumatoid arthritis, osteoporosis, axial spondyloarthritis, psoriatic arthritis, Chro.....See More See More

Auditor: PwC Reviseurs d'Entreprises sccrl
Legal Advisor:
Table could not be created because no data was found
Brands, Divisions and AffiliatesTop Salaries
Cimzia
Briviact
Keppra
Vimpat
Neupro
Nootropil
Xyrem
Element Genomics
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: